2021 HFA/EACVI/EHRA/EAPCI立场声明：心力衰竭患者继发二尖瓣反流的管理

2021-03-18 欧洲心力衰竭协会 Eur Heart J. 2021 Mar 18

2021年3月，欧洲心力衰竭协会(HFA)联合欧洲协会心血管影像协会(EACVI)等多家学会组织共同发布了心力衰竭患者继发二尖瓣反流的管理声明。继发性（或功能性）二尖瓣反流（SMR）常发生于慢性心力衰

中文标题：

英文标题：

The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association

发布机构：

欧洲心力衰竭协会

发布日期：

2021-03-18

简要介绍：

2021年3月，欧洲心力衰竭协会(HFA)联合欧洲协会心血管影像协会(EACVI)等多家学会组织共同发布了心力衰竭患者继发二尖瓣反流的管理声明。继发性（或功能性）二尖瓣反流（SMR）常发生于慢性心力衰竭患者，其左室射血分数降低，继发性SMR可促使心衰患者症状和体征不断进展，预后较差。本文主要针对心力衰竭患者继发二尖瓣反流的评估和管理提供最新的实用方法。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=7e5c51c0020e8a6e, title=2021 HFA/EACVI/EHRA/EAPCI立场声明：心力衰竭患者继发二尖瓣反流的管理, enTitle=The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association, guiderFrom=Eur Heart J. 2021 Mar 18, authorId=0, author=, summary=2021年3月，欧洲心力衰竭协会(HFA)联合欧洲协会心血管影像协会(EACVI)等多家学会组织共同发布了心力衰竭患者继发二尖瓣反流的管理声明。继发性（或功能性）二尖瓣反流（SMR）常发生于慢性心力衰, cover=https://img.medsci.cn/2021331/1617204858833_2020535.jpg, journalId=0, articlesId=null, associationId=395, associationName=欧洲心力衰竭协会, associationIntro=欧洲心力衰竭协会(HFA,Heart Failure Association)是注册于欧洲心脏病学会ESC的分支机构，于2004年8月在慕尼黑正式启动，由已解散的前ESC工作心衰组创建。拥有约3800会员，致力于心衰的教育和研究。, copyright=0, guiderPublishedTime=Thu Mar 18 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年3月，欧洲心力衰竭协会(HFA)联合欧洲协会心血管影像协会(EACVI)等多家学会组织共同发布了心力衰竭患者继发二尖瓣反流的管理声明。继发性（或功能性）二尖瓣反流（SMR）常发生于慢性心力衰竭患者，其左室射血分数降低，继发性SMR可促使心衰患者症状和体征不断进展，预后较差。本文主要针对心力衰竭患者继发二尖瓣反流的评估和管理提供最新的实用方法。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=335, tagName=心力衰竭), TagDto(tagId=2993, tagName=二尖瓣反流)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=335, guiderKeyword=心力衰竭, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3240, appHits=238, showAppHits=0, pcHits=582, showPcHits=3002, likes=3, shares=20, comments=19, approvalStatus=1, publishedTime=Wed Mar 31 23:38:03 CST 2021, publishedTimeString=2021-03-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Mar 31 23:34:28 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 01:02:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=心力衰竭患者继发二尖瓣反流的管理.pdf)])

心力衰竭患者继发二尖瓣反流的管理.pdf

下载请点击：

评论区 (15)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1063639, encodeId=2cdd1063639d9, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Mon Oct 25 01:54:52 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998463, encodeId=d02e998463d2, content=写的好<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=白鸽ing, createdTime=Sun Jul 11 13:02:55 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998462, encodeId=623c99846234, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=ms9000001652264710, createdTime=Sun Jul 11 12:59:41 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998461, encodeId=7ef9998461a7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=ms9000001652264710, createdTime=Sun Jul 11 12:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970920, encodeId=a7a49e09209b, content=更细化, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIVWjGic9CJTgpxEZmhk76ojLdROwquUY4SSU7iaWbb54euRwJ39wgueRK8REsEu3gdcU7ymoE47Tug/132, createdBy=01192443867, createdName=th555happy, createdTime=Fri Jun 04 16:55:35 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
2021-10-25 Doctoryangbai

点赞

60 0
[GetPortalCommentsPageByObjectIdResponse(id=1063639, encodeId=2cdd1063639d9, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Mon Oct 25 01:54:52 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998463, encodeId=d02e998463d2, content=写的好<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=白鸽ing, createdTime=Sun Jul 11 13:02:55 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998462, encodeId=623c99846234, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=ms9000001652264710, createdTime=Sun Jul 11 12:59:41 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998461, encodeId=7ef9998461a7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=ms9000001652264710, createdTime=Sun Jul 11 12:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970920, encodeId=a7a49e09209b, content=更细化, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIVWjGic9CJTgpxEZmhk76ojLdROwquUY4SSU7iaWbb54euRwJ39wgueRK8REsEu3gdcU7ymoE47Tug/132, createdBy=01192443867, createdName=th555happy, createdTime=Fri Jun 04 16:55:35 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
2021-07-11 白鸽ing

写的好#学习#

73 0
[GetPortalCommentsPageByObjectIdResponse(id=1063639, encodeId=2cdd1063639d9, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Mon Oct 25 01:54:52 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998463, encodeId=d02e998463d2, content=写的好<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=白鸽ing, createdTime=Sun Jul 11 13:02:55 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998462, encodeId=623c99846234, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=ms9000001652264710, createdTime=Sun Jul 11 12:59:41 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998461, encodeId=7ef9998461a7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=ms9000001652264710, createdTime=Sun Jul 11 12:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970920, encodeId=a7a49e09209b, content=更细化, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIVWjGic9CJTgpxEZmhk76ojLdROwquUY4SSU7iaWbb54euRwJ39wgueRK8REsEu3gdcU7ymoE47Tug/132, createdBy=01192443867, createdName=th555happy, createdTime=Fri Jun 04 16:55:35 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
2021-07-11 ms9000001652264710

好

66 0
[GetPortalCommentsPageByObjectIdResponse(id=1063639, encodeId=2cdd1063639d9, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Mon Oct 25 01:54:52 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998463, encodeId=d02e998463d2, content=写的好<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=白鸽ing, createdTime=Sun Jul 11 13:02:55 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998462, encodeId=623c99846234, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=ms9000001652264710, createdTime=Sun Jul 11 12:59:41 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998461, encodeId=7ef9998461a7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=ms9000001652264710, createdTime=Sun Jul 11 12:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970920, encodeId=a7a49e09209b, content=更细化, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIVWjGic9CJTgpxEZmhk76ojLdROwquUY4SSU7iaWbb54euRwJ39wgueRK8REsEu3gdcU7ymoE47Tug/132, createdBy=01192443867, createdName=th555happy, createdTime=Fri Jun 04 16:55:35 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
2021-07-11 ms9000001652264710

好

64 0
[GetPortalCommentsPageByObjectIdResponse(id=1063639, encodeId=2cdd1063639d9, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Mon Oct 25 01:54:52 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998463, encodeId=d02e998463d2, content=写的好<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=白鸽ing, createdTime=Sun Jul 11 13:02:55 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998462, encodeId=623c99846234, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=ms9000001652264710, createdTime=Sun Jul 11 12:59:41 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998461, encodeId=7ef9998461a7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/a2307db685c746059198faf3e21e6dae/f950a47a34784a25943a4e0dec41721c.jpg, createdBy=e6025546312, createdName=ms9000001652264710, createdTime=Sun Jul 11 12:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970920, encodeId=a7a49e09209b, content=更细化, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIVWjGic9CJTgpxEZmhk76ojLdROwquUY4SSU7iaWbb54euRwJ39wgueRK8REsEu3gdcU7ymoE47Tug/132, createdBy=01192443867, createdName=th555happy, createdTime=Fri Jun 04 16:55:35 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
2021-06-04 th555happy

更细化

70 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

2021 HFA/EACVI/EHRA/EAPCI立场声明：心力衰竭患者继发二尖瓣反流的管理

相关指南

拓展阅读

科室

工具

服务